Compare Eli Lilly And Co (LLY) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Norwegian Cruise Line Holdings Ltd — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while Norwegian Cruise Line Holdings Ltd trades at $19.47 (market cap $8.95B). The key difference: Eli Lilly And Co is far larger — about 114× Norwegian Cruise Line Holdings Ltd's market cap, and Eli Lilly And Co pays a 0.6% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals.
| LLY | NCLH | |
|---|---|---|
Market Cap | $1.02T | $8.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $26.94 |
52-Week Low | $625.65 | $14.79 |
Enterprise Value | $1.06T | $23.92B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
